Publications by authors named "Carrie Taylor"

Claim this Profile
E
Efficacy and Safety of Marstacimab Prophylaxis in Hemophilia A/B With Inhibitors: Results from the Phase 3 BASIS Trial.
Davide Matino, Suchitra Acharya, Carrie Turich Taylor, Pengling Sun, Delphine Agathon

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial.
Davide Matino, Andrew Palladino, Carrie Turich Taylor, Eunhee Hwang, Sangeeta Raje

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF-1 Assessment During Weekly Somatrogon Treatment in Pediatric Patients With GH Deficiency.
Satyaprakash Nayak, Michael P Wajnrajch, Joan Korth-Bradley, Carrie Turich Taylor, Marc Thomas

J Endocr Soc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication.
Aristides K Maniatis, Mauri Carakushansky, Sonya Galcheva, Gnanagurudasan Prakasam, Larry A Fox, Carrie Turich Taylor

Ther Adv Endocrinol Metab· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the efficacy and safety of weekly somatrogon with daily somatropin to treat children with growth hormone deficiency: a plain language summary of publication.
Cheri L Deal, Joel Steelman, Elpis Vlachopapadopoulou, Renata Stawerska, Lawrence A Silverman, Carrie Turich Taylor

Ther Adv Endocrinol Metab· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
Cheri L Deal, Joel Steelman, Elpis Vlachopapadopoulou, Renata Stawerska, Lawrence A Silverman, Carrie Turich Taylor

J Clin Endocrinol Metab· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient perspectives of pain and function after knee replacement: a systematic review and meta-synthesis of qualitative studies.
Carrie E V Taylor, Carolyn M Murray, Tasha R Stanton

Pain Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients with Locally Advanced or Metastatic Cancers.
Adi Diab, Omid Hamid, John A Thompson, Willeke Ros, Ferry A L M Eskens, Carrie Turich Taylor

Clin Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma.
David A Reardon, Annick Desjardins, Olivier Rixe, Timothy Cloughesy, Shilpa Alekar, Carrie Turich Taylor

Invest New Drugs· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma.
Marcus Noel, Eileen M O'Reilly, Brian M Wolpin, David P Ryan, Andrea J Bullock, Carrie T Taylor

Invest New Drugs· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors.
Geoffrey I Shapiro, Ulka N Vaishampayan, Patricia LoRusso, Jeremy Barton, Steven Hua, Carrie T Taylor

Invest New Drugs· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar PF-05280014 with trastuzumab in healthy volunteers (REFLECTIONS B327-01).
Donghua Yin, Kerry B Barker, Ruifeng Li, Xu Meng, Steven D Reich, Carrie T Taylor

Br J Clin Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of universal disinfectant cap implementation on central line-associated bloodstream infections.
Katreena Collette Merrill, Sharon Sumner, Lorraine Linford, Carrie Taylor, Christopher Macintosh

Am J Infect Control· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoeconomics of cancer therapies: considerations with the introduction of biosimilars.
David Henry, Carrie Taylor

Semin Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing clinical trials for biosimilars.
Lynne A Bui, Carrie Taylor

Semin Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A six-year descriptive study of hospital-associated infection in trauma patients: demographics, injury features, and infection patterns.
Harrison M Lazarus, Jolene Fox, James F Lloyd, R Scott Evans, Rouett Abouzelof, Carrie Taylor

Surg Infect (Larchmt)· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are you prepared to deal with a high-risk respiratory illness?
Carrie Taylor, Ann Allen, Sharon Sumner, Mark Vought

J Emerg Nurs· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trauma patient hospital-associated infections: risks and outcomes.
Harrison M Lazarus, Jolene Fox, John P Burke, James F Lloyd, Gregory L Snow, Carrie Taylor

J Trauma· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance of medical device-related hazards and adverse events in hospitalized patients.
Matthew H Samore, R Scott Evans, April Lassen, Patricia Gould, James Lloyd, Carrie Taylor

JAMA· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In utero cocaine, discriminative avoidance learning with low-salient stimuli and learning-related neuronal activity in rabbits (Oryctolagus cuniculus).
Michael Gabriel, Carrie Taylor, Lauren Burhans

Behav Neurosci· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prenatal Exposure to Cocaine Impairs Neuronal Coding of Attention and Discriminative Learning.
Michael Gabriel, Carrie Taylor

Ann N Y Acad Sci· June 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis